Stock listing
NASDAQ:DMRA Damora Therapeutics, Inc. Stock
Home listing (NASDAQ) of Damora Therapeutics, Inc.
Follow Damora Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:DMRA
$21.49 USD -0.52 (-2.4%)
Close on Oct 30, 2026
- Day range
- $21.05 – $22.20 USDOct 30, 2026
- Volume
- 339,515 sharesOct 30, 2026
- Market cap
- $1.33B USDAt the close on Oct 30, 2026 · price × 61.74M shares outstanding
- 52-week range
- $4.95 – $38.33 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $12.57M USDMedian day 370,200 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:DMRA · Home | $21.49 USD | -0.52 (-2.4%) | 339,515 | $21.95 | $22.20 | $21.05 | $22.01 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:DMRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $21.49 | -0.52 | -2.4% | $21.95 | $22.20 | $21.05 | 339,515 | |
| $22.01 | +0.40 | +1.9% | $22.06 | $23.21 | $21.50 | 460,310 | |
| $21.61 | -0.35 | -1.6% | $21.93 | $22.51 | $20.46 | 341,763 | |
| $21.96 | +0.70 | +3.3% | $21.26 | $22.27 | $20.23 | 286,092 | |
| $21.26 | +0.17 | +0.8% | $21.19 | $21.78 | $21.09 | 641,718 | |
| $21.09 | -0.62 | -2.9% | $21.40 | $21.53 | $20.46 | 359,783 | |
| $21.71 | +0.18 | +0.8% | $21.45 | $21.88 | $20.92 | 420,641 | |
| $21.53 | +0.86 | +4.2% | $20.88 | $22.68 | $20.66 | 683,090 | |
| $20.67 | +1.40 | +7.3% | $19.30 | $20.92 | $19.30 | 242,321 | |
| $19.27 | +0.83 | +4.5% | $18.56 | $19.94 | $18.52 | 293,164 | |
| $18.44 | -0.30 | -1.6% | $18.69 | $18.80 | $17.49 | 836,700 | |
| $18.74 | +0.31 | +1.7% | $18.59 | $18.89 | $17.84 | 357,600 | |
| $18.43 | -0.13 | -0.7% | $18.21 | $18.98 | $18.00 | 277,600 | |
| $18.56 | -1.695 | -8.4% | $20.09 | $20.28 | $18.50 | 285,200 | |
| $20.26 | -0.825 | -3.9% | $20.93 | $21.26 | $20.05 | 267,900 | |
| $21.08 | +0.52 | +2.5% | $20.53 | $21.86 | $20.44 | 368,700 | |
| $20.56 | +0.32 | +1.6% | $19.96 | $20.87 | $19.22 | 341,800 | |
| $20.24 | +0.69 | +3.5% | $19.36 | $20.35 | $18.69 | 488,800 | |
| $19.55 | -0.67 | -3.3% | $20.42 | $20.48 | $18.20 | 1,171,600 | |
| $20.22 | -0.43 | -2.1% | $20.64 | $20.70 | $19.54 | 556,100 | |
| $20.65 | +0.42 | +2.1% | $20.55 | $20.77 | $19.59 | 692,900 | |
| $20.23 | -1.05 | -4.9% | $20.51 | $21.25 | $20.20 | 354,600 | |
| $21.28 | +0.62 | +3.0% | $20.78 | $21.85 | $20.31 | 563,000 | |
| $20.66 | -0.09 | -0.4% | $20.67 | $20.82 | $20.16 | 376,400 | |
| $20.75 | +0.09 | +0.4% | $21.26 | $21.59 | $19.83 | 514,900 | |
| $20.66 | +0.39 | +1.9% | $20.80 | $20.80 | $19.80 | 1,431,800 | |
| $20.27 | -0.17 | -0.8% | $20.38 | $20.73 | $19.39 | 875,200 | |
| $20.44 | -1.97 | -8.8% | $22.12 | $22.12 | $19.96 | 1,067,200 | |
| $22.41 | -0.44 | -1.9% | $23.21 | $23.43 | $21.95 | 355,200 | |
| $22.85 | +0.26 | +1.2% | $22.80 | $23.33 | $22.01 | 618,200 | |
| $22.59 | -0.19 | -0.8% | $22.94 | $23.44 | $22.02 | 3,316,800 | |
| $22.78 | -1.75 | -7.1% | $24.96 | $25.49 | $22.74 | 605,100 | |
| $24.53 | -0.22 | -0.9% | $24.88 | $25.27 | $23.91 | 1,241,800 | |
| $24.75 | -3.64 | -12.8% | $28.00 | $28.17 | $24.14 | 1,677,900 | |
| $28.39 | +0.29 | +1.0% | $28.42 | $29.18 | $28.00 | 372,100 | |
| $28.10 | +1.26 | +4.7% | $27.32 | $28.53 | $26.87 | 525,400 | |
| $26.84 | +0.57 | +2.2% | $25.87 | $27.78 | $25.63 | 639,800 | |
| $26.27 | -2.90 | -9.9% | $28.77 | $29.29 | $26.26 | 500,100 | |
| $29.17 | -0.89 | -3.0% | $29.66 | $30.74 | $28.89 | 560,000 | |
| $30.06 | +2.06 | +7.4% | $27.49 | $30.35 | $27.39 | 295,800 | |
| $28.00 | -0.18 | -0.6% | $28.52 | $28.60 | $27.40 | 328,200 | |
| $28.18 | +0.04 | +0.1% | $28.36 | $29.38 | $27.82 | 462,900 | |
| $28.14 | -0.04 | -0.1% | $28.10 | $28.45 | $27.12 | 272,700 | |
| $28.18 | -0.82 | -2.8% | $28.93 | $28.93 | $26.53 | 497,000 | |
| $29.00 | -1.60 | -5.2% | $30.38 | $30.71 | $28.42 | 371,700 | |
| $30.60 | +0.21 | +0.7% | $30.18 | $31.11 | $29.87 | 171,300 | |
| $30.39 | -0.23 | -0.8% | $30.48 | $30.88 | $30.10 | 185,900 | |
| $30.62 | +0.31 | +1.0% | $30.55 | $31.64 | $30.54 | 205,709 | |
| $30.31 | -0.51 | -1.7% | $30.67 | $31.49 | $29.70 | 319,817 | |
| $30.82 | +0.51 | +1.7% | $30.45 | $31.38 | $30.15 | 159,900 | |
| $30.31 | -2.13 | -6.6% | $31.84 | $32.07 | $30.12 | 226,500 | |
| $32.44 | +0.64 | +2.0% | $32.43 | $33.56 | $31.41 | 486,700 | |
| $31.80 | +0.71 | +2.3% | $30.74 | $32.17 | $30.29 | 485,700 | |
| $31.09 | +0.05 | +0.2% | $31.10 | $31.79 | $30.81 | 362,700 | |
| $31.04 | +0.31 | +1.0% | $30.37 | $31.52 | $29.50 | 260,700 | |
| $30.73 | -0.27 | -0.9% | $31.13 | $31.13 | $30.16 | 227,800 | |
| $31.00 | +0.64 | +2.1% | $30.29 | $31.55 | $29.89 | 314,300 | |
| $30.36 | +0.82 | +2.8% | $29.89 | $30.78 | $29.14 | 234,900 | |
| $29.54 | -0.38 | -1.3% | $29.72 | $30.31 | $29.22 | 216,200 | |
| $29.92 | +0.04 | +0.1% | $30.11 | $30.66 | $29.09 | 197,400 | |
| $29.88 | -0.95 | -3.1% | $30.44 | $31.10 | $29.39 | 696,400 | |
| $30.83 | +0.81 | +2.7% | $30.55 | $31.77 | $29.05 | 607,300 | |
| $30.02 | +1.46 | +5.1% | $28.85 | $30.58 | $28.48 | 551,100 | |
| $28.56 | -0.43 | -1.5% | $29.67 | $29.90 | $28.42 | 227,800 | |
| $28.99 | -0.22 | -0.8% | $29.21 | $30.27 | $28.65 | 314,500 | |
| $29.21 | +0.88 | +3.1% | $29.05 | $30.02 | $28.71 | 334,000 |
- Ticker
- NASDAQ:DMRA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 5, 2026
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 23 slides
Latest news
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4)
Oct 5, 2026
Closed $20.22 (-2.1%) on Oct 5, 2026
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 2, 2026
Closed $20.65 (+2.1%) on Oct 2, 2026
Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Aug 10, 2026
Closed $30.36 (+2.8%) on Aug 11, 2026
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis
Aug 5, 2026
Closed $30.83 (+2.7%) on Aug 5, 2026
Damora Announces Redomestication from Delaware to Cayman Islands
Jul 17, 2026
Closed $31.48 (+4.1%) on Jul 17, 2026
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
May 12, 2026
Closed $24.16 (+4.6%) on May 13, 2026
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
Mar 23, 2026
Closed $23.05 (+27.1%) on Mar 23, 2026
Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Mar 19, 2026
Closed $18.14 (-5.5%) on Mar 20, 2026
Decks
Investor Presentation (August 2026)
Investor deck · 23 slides · August 2026
Investor Presentation (May 2026)
Investor deck · 22 slides · May 2026
Damora Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 10 in the last 12 months · 10 in all · newest Oct 5, 2026 · oldest 2026
- Decks
- 2 decks · latest August 2026
Where Damora Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:DMRA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:DMRA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Damora Therapeutics, Inc.